Back to Search
PAUL DEL BIANCO, MD
MD
Internal Medicine Physician
NPI: 1386622520Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD040061-L(PA)
Research & Publications (20)
Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery.
PMID 19629538·Support Care Cancer·2010
8-other
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.
PMID 18825381·Cancer Chemother Pharmacol·2009
3-trial
Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery.
PMID 18459006·Ann Surg Oncol·2008
4-observational
Role of resection margins in patients treated with breast conservation surgery.
PMID 18327818·Cancer·2008
8-other
A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
PMID 18216523·Ann Surg·2008
4-observational
Clinical impact of false-negative sentinel lymph nodes in breast cancer.
PMID 17764888·Eur J Surg Oncol·2008
2-rct
Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
PMID 17614245·Eur J Surg Oncol·2008
4-observational
Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center.
PMID 17325863·Leuk Lymphoma·2007
3-trial
Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer.
PMID 17245338·Br J Cancer·2007
3-trial
IgM multiple myeloma: report of four cases and review of the literature.
PMID 16966268·Leuk Lymphoma·2006
5-case
Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
PMID 16671090·Int J Cancer·2006
8-other
Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI - Mel.A.) [ISRCTN75125874].
PMID 16504154·BMC Cancer·2006
3-trial
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.
PMID 16461311·Haematologica·2006
2-rct
Social isolation selectively reduces hippocampal brain-derived neurotrophic factor without altering plasma corticosterone.
PMID 16455145·Behav Brain Res·2006
4-observational
Predicting tumor outcome following cancer vaccination by monitoring quantitative and qualitative CD8+ T cell parameters.
PMID 16424232·J Immunol·2006
7-preclinical
Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
PMID 16336503·Neurogastroenterol Motil·2005
7-preclinical
Metabotropic glutamate receptors and neuroadaptation to antidepressants: imipramine-induced down-regulation of beta-adrenergic receptors in mice treated with metabotropic glutamate 2/3 receptor ligands.
PMID 15934953·J Neurochem·2005
7-preclinical
A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer.
PMID 15894548·Ann Oncol·2005
3-trial
Treatment of 72 newly diagnosed Waldenstrom macroglobulinemia cases with oral melphalan, cyclophosphamide, and prednisone: results and cost analysis.
PMID 15611977·Cancer·2005
8-other
Hippocampal prosaposin changes during stress: a glucocorticoid-independent event.
PMID 15132426·Hippocampus·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- CORNER OF ROUTE N12 AND N7
FORT DEFIANCE, AZ 86504 - Phone
- (928) 729-8000
Quick Facts
- NPI
- 1386622520
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile